Specificity of the T Cells That Mediate and Suppress Adoptive Immunotherapy of Established Tumors
- 1 July 1984
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 36 (1) , 27-37
- https://doi.org/10.1002/jlb.36.1.27
Abstract
This study was designed to investigate the specificity of the T cells that express and suppress antitumor immunity in a model of adoptive immunization against established tumors. Results obtained with the P815 mastocytoma, L5178Y lymphoma, and P388 lymphoma showed, in agreement with previous findings from this laboratory, that an intravenous infusion of splenic T cells from immunized mice can cause the regression of a tumor growing in T-cell-deficient mice. So far as specificity of adoptive immunity is concerned, reciprocal passive transfer experiments with these three tumors revealed that T cells from donor mice immunized against the P815 tumor are not capable of causing regression of the P388 tumor or L5178Y tumor, even if both the P815 and L5178Y tumors are growing in the same host. Similarly splenic T cells from mice immunized against the P388 tumor or L5178Y tumor had no effect on growth of the P815 tumor. Suppression of adoptive immunity was also specific, in that passively transferred suppressor T cells from mice bearing a progressive P815 tumor were capable of suppressing adoptive T-cell-mediated regression of the P815 tumor, but not the P388 tumor growing in T-cell-deficient recipients. Reciprocally, P388 suppressor spleen cells from mice bearing a progressive P388 tumor prevented adoptive T-cell-mediated regression of the P388 tumor, but not the P815 tumor. The results indicate, therefore, that the T cells from immunized mice that mediate adoptive antitumor immunity and the T cells from tumor-bearing mice that suppress the expression of this immunity are specific for the tumor that evokes their generation.Keywords
This publication has 15 references indexed in Scilit:
- Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations.The Journal of Experimental Medicine, 1981
- Antigen- and receptor-driven regulatory mechanisms. VIII. Suppression of idiotype-negative, p-azobenzenearsonate-specific T cells results from the interaction of an anti-idiotypic second-order T suppressor cell with a cross-reactive-idiotype-positive, p-azobenzenearsonate-primed T cell target.The Journal of Experimental Medicine, 1981
- Suppression of tumor rejection by autologous anti-idiotypic immunityProceedings of the National Academy of Sciences, 1980
- T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.The Journal of Experimental Medicine, 1980
- In Vivo Elimination by Specific Effector Cells of an Established Syngeneic Rat Moloney Virus-Induced SarcomaThe Journal of Immunology, 1979
- Role of Different T Cell Sets in the Rejection of Syngeneic Chemically Induced TumorsThe Journal of Immunology, 1979
- Regression of Established Intradermal Tumors and Lymph Node Metastases in Guinea Pigs After Systemic Transfer of Immune Lymphoid CellsJNCI Journal of the National Cancer Institute, 1977
- DEMONSTRATION OF RESISTANCE AGAINST METHYLCHOLANTHRENE-INDUCED SARCOMAS IN THE PRIMARY AUTOCHTHONOUS HOST1960
- Immunity to Methylcholanthrene-Induced SarcomasJNCI Journal of the National Cancer Institute, 1957
- ANTIGENIC PROPERTIES OF METHYLCHOLANTHRENE-INDUCED TUMORS IN MICE OF THE STRAIN OF ORIGIN1953